BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33125690)

  • 1. Aberrant expression of semaphorin 6B affects cell phenotypes in thyroid carcinoma by activating the Notch signalling pathway.
    Lv XJ; Chen X; Wang Y; Yu S; Pang L; Huang C
    Endokrynol Pol; 2021; 72(1):29-36. PubMed ID: 33125690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
    Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
    Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 4. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
    Lee J; Seol MY; Jeong S; Kwon HJ; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
    J Mol Endocrinol; 2015 Apr; 54(2):115-24. PubMed ID: 25608512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform.
    D'Apice L; Costa V; Valente C; Trovato M; Pagani A; Manera S; Regolo L; Zambelli A; Ciccodicola A; De Berardinis P
    Biochim Biophys Acta; 2013 Oct; 1830(10):4543-53. PubMed ID: 23665584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines.
    Correa RG; Sasahara RM; Bengtson MH; Katayama ML; Salim AC; Brentani MM; Sogayar MC; de Souza SJ; Simpson AJ
    Genomics; 2001 May; 73(3):343-8. PubMed ID: 11350127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA circ_0067934 Overexpression Correlates with Poor Prognosis and Promotes Thyroid Carcinoma Progression.
    Wang H; Yan X; Zhang H; Zhan X
    Med Sci Monit; 2019 Feb; 25():1342-1349. PubMed ID: 30779728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
    Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
    Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
    Shen ED; Zeng Q
    Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
    Song SG; Yu HY; Ma YW; Zhang F; Xu XY
    Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
    Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
    J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
    Feng X; Li T; Liu Z; Shi Y; Peng Y
    Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy.
    Hamanaka K; Imagawa E; Koshimizu E; Miyatake S; Tohyama J; Yamagata T; Miyauchi A; Ekhilevitch N; Nakamura F; Kawashima T; Goshima Y; Mohamed AR; Ch'ng GS; Fujita A; Azuma Y; Yasuda K; Imamura S; Nakashima M; Saitsu H; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Matsumoto N
    Am J Hum Genet; 2020 Apr; 106(4):549-558. PubMed ID: 32169168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
    Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
    Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.